Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
Top Cited Papers
- 1 February 2008
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 371 (9610), 395-403
- https://doi.org/10.1016/s0140-6736(08)60203-2
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- New thrombopoietic growth factorsBlood, 2007
- Idiopathic cyclic thrombocytopeniaBlood Reviews, 2005
- Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITPBlood, 2004
- Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpuraBlood, 2004
- Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in miceBlood, 2002
- Serum Thrombopoietin Level in Various Hematological DiseasesThe International Journal of Cell Cloning, 1996
- Very Low Dose Danazol in Idiopathic Thrombocytopenic Purpura and its Role as an Immune ModulatorThe American Journal of the Medical Sciences, 1989
- Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.JCI Insight, 1987
- HIGH-DOSE INTRAVENOUS IgG IN ADULTS WITH AUTOIMMUNE THROMBOCYTOPENIAThe Lancet, 1983
- Chronic Idiopathic Thrombocytopenic PurpuraNew England Journal of Medicine, 1981